Q-linea AB secures SEK 151.5 million in funding

Q-linea AB, a diagnostic company focused on developing and delivering solutions to accurately and rapidly diagnose infectious diseases, announced today that the company secured SEK 151.5 million from existing shareholders and a group of Swedish investors. Lead investors were Investment AB Öresund and the Fourth AP fund. Read more